Cargando…

Incidence of Active Tuberculosis within One Year after Tumor Necrosis Factor Inhibitor Treatment according to Latent Tuberculosis Infection Status in Patients with Inflammatory Bowel Disease

BACKGROUND: We investigated the incidence of active tuberculosis among patients with inflammatory bowel disease (IBD) treated with tumor necrosis factor (TNF) inhibitors, with or without latent tuberculosis infection (LTBI). METHODS: The study was performed at a Korean tertiary referral center betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Jieun, Jeong, Dae Hyun, Han, Minkyu, Yang, Suk-Kyun, Byeon, Jeong-Sik, Ye, Byong Duk, Park, Sang Hyoung, Hwang, Sung Wook, Shim, Tae Sun, Jo, Kyung-Wook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236083/ https://www.ncbi.nlm.nih.gov/pubmed/30450023 http://dx.doi.org/10.3346/jkms.2018.33.e292

Ejemplares similares

The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea
por: Choi, Myeong Geun, et al.
Publicado: (2022)

Risk and characteristics of tuberculosis after anti-tumor necrosis factor therapy for inflammatory bowel disease: a hospital-based cohort study from Korea
por: Lee, Jae Yong, et al.
Publicado: (2021)

Frequency of Positive Conversion of Interferon-Gamma Release Assay Results Among Patients With Inflammatory Bowel Disease Treated With Non-tumor Necrosis Factor Inhibitors
por: Kim, Kyuwon, et al.
Publicado: (2021)

Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA
por: Jeong, Dae Hyun, et al.
Publicado: (2018)

Active Tuberculosis Incidence and Characteristics in Patients Treated with Tumor Necrosis Factor Antagonists According to Latent Tuberculosis Infection
por: Lee, Eun Hye, et al.
Publicado: (2017)

The Clinical Features of Inflammatory Bowel Disease in Patients with Obesity
por: Kim, Seong Kyun, et al.
Publicado: (2021)

Seroprevalence of viral infectious diseases and associated factors in Korean patients with inflammatory bowel diseases
por: Hong, Hee Seung, et al.
Publicado: (2022)

Temporal trends in the misdiagnosis rates between Crohn’s disease and intestinal tuberculosis
por: Seo, Hyungil, et al.
Publicado: (2017)

Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea
por: Lee, Ho-Su, et al.
Publicado: (2016)

Insufficient vaccination and inadequate immunization rates among Korean patients with inflammatory bowel diseases
por: Ryu, Han Hee, et al.
Publicado: (2021)

The Risk of Tuberculosis in Korean Patients with Inflammatory Bowel Disease Receiving Tumor Necrosis Factor-α Blockers
por: Byun, Ja Min, et al.
Publicado: (2015)

Prevalence of Latent Tuberculosis Infection among Medical Students in South Korea
por: Jung, Da Ho, et al.
Publicado: (2012)

Usefulness of C-Reactive Protein as a Disease Activity Marker in Crohn’s Disease according to the Location of Disease
por: Yang, Dong-Hoon, et al.
Publicado: (2015)

Effect of Biofeedback Therapy in Constipation According to Rectal Sensation
por: Ahn, Ji Yong, et al.
Publicado: (2013)

Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy
por: Shim, Tae Sun
Publicado: (2014)

Clinical outcomes of colonoscopic polypectomy with strategic surveillance colonoscopies in patients with 10 or more polyps
por: Park, Jin Hwa, et al.
Publicado: (2023)

Fecal S100A12 is associated with future hospitalization and step-up of medical treatment in patients with Crohn’s disease in clinical remission: a pilot study
por: Lee, Sun-Ho, et al.
Publicado: (2022)

Clinical outcomes of submucosal colorectal cancer diagnosed after endoscopic resection: a focus on the need for surgery
por: Choi, Yun Sik, et al.
Publicado: (2020)

Changes in prevalence and perception of complementary and alternative medicine use in Korean inflammatory bowel disease patients: results of an 8-year follow-up survey
por: Lee, Sun-Ho, et al.
Publicado: (2020)

Diagnosis and Treatment of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists in Korea
por: Yun, Jong Wook, et al.
Publicado: (2007)

Postpolypectomy Fever, a Rare Adverse Event of Polypectomy: Nested Case-Control Study
por: Lee, Seung-Hoon, et al.
Publicado: (2014)

Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study
por: Lee, Jin Wook, et al.
Publicado: (2021)

A Surveillance Endoscopy Strategy Based on Local Recurrence Rates after Colorectal Endoscopic Submucosal Dissection
por: Park, Jin Hwa, et al.
Publicado: (2021)

Risk factors and prognostic value of acute severe lower gastrointestinal bleeding in Crohn’s disease
por: Yoon, Jiyoung, et al.
Publicado: (2021)

Clinical features of active tuberculosis that developed during anti-tumor necrosis factor therapy in patients with inflammatory bowel disease
por: Lee, Jang Wook, et al.
Publicado: (2016)

Long-term Outcomes of Adalimumab Therapy in Korean Patients with Ulcerative Colitis: A Hospital-Based Cohort Study
por: Oh, Eun Hye, et al.
Publicado: (2020)

Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel
por: Kim, Gwang-Un, et al.
Publicado: (2021)

Elevated C-reactive protein is associated with disease progression in patients with mild Crohn’s disease
por: Kwak, Min Seob, et al.
Publicado: (2016)

Prevalence of Fructose Malabsorption in Patients With Irritable Bowel Syndrome After Excluding Small Intestinal Bacterial Overgrowth
por: Jung, Kee Wook, et al.
Publicado: (2018)

Local recurrence and subsequent endoscopic treatment after endoscopic piecemeal mucosal resection with or without precutting in the colorectum
por: Seo, Myeongsook, et al.
Publicado: (2017)

Clinical course of ulcerative colitis patients who develop acute pancreatitis
por: Kim, Jong Wook, et al.
Publicado: (2017)

A Comparison of 2 L of Polyethylene Glycol and 45 mL of Sodium Phosphate versus 4 L of Polyethylene Glycol for Bowel Cleansing: A Prospective Randomized Trial
por: Bae, Suh Eun, et al.
Publicado: (2013)

Bronchoesophageal fistula in a patient with Crohn’s disease receiving anti-tumor necrosis factor therapy
por: Oh, Kyunghwan, et al.
Publicado: (2023)

Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients
por: Yoon, Jiyoung, et al.
Publicado: (2021)

Patient Descriptions of Rectal Effluents May Help to Predict the Quality of Bowel Preparation With Photographic Examples
por: So, Hoonsub, et al.
Publicado: (2015)

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease
por: Kwak, Min Seob, et al.
Publicado: (2018)

Latent tuberculosis screening tests and active tuberculosis infection rates in Turkish inflammatory bowel disease patients under anti-tumor necrosis factor therapy
por: Çekiç, Cem, et al.
Publicado: (2015)

Current Status of Fluoroquinolone Use for Treatment of Tuberculosis in a Tertiary Care Hospital in Korea
por: Kang, Bo Hyoung, et al.
Publicado: (2017)

Prevalence and risk factors of bowel symptoms in Korean patients with ulcerative colitis in endoscopic remission: a retrospective study
por: Nam, Kwangwoo, et al.
Publicado: (2021)

Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn’s disease
por: Yang, Kwan Mo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_pg6ftigckircn6ed3r2kgg7rnq